Referenzstandards von Eurofins | PHAST

USP-1711455

Verbascoside (15 mg) (2-(3,4-Dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-4-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-Beta-D-glucopyranoside)
F050Y0
‭61276-17-3‬
x
x
x